Anticoagulation with heparin is the current mainstay treatment for Cerebral Venous Sinus Thrombosis (CVST). Endovascular treatment is increasingly being used to treat patients with CVST who are non-responsive to anticoagulation. These more aggressive interventions include catheter-based local chemical thrombolysis, balloon angioplasty and mechanical thrombectomy with uncertain safety and efficacy. Here we describe the first reported clinical experience using the INARI FlowTriever system to treat a patient presented with focal weakness and found to have diffuse CVST.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718648 | PMC |
| http://dx.doi.org/10.3389/fneur.2021.778842 | DOI Listing |
Publication Analysis
Top Keywords
clinical experience
8
cerebral venous
8
venous sinus
8
sinus thrombosis
8
inari flowtriever
8
flowtriever system
8
label endovascular
4
endovascular clinical
4
experience treat
4
treat diffuse
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!